evaluate the pharmaceuticals company saxenda on glp-1 drugs for diabetes Saxenda® Liraglutide Weight Loss Program Older GLP-1 drug may help

This initial evaluation should also include kidney function tests, as these medications are generally avoided in patients with severe kidney dysfunction

Additional trials are ongoing

Dhaliwal A, Quinlan JI, Overthrow K, Greig C, Lord JM, Armstrong MJ, et al

25 Given concerns that skeletal muscle loss may predispose patients to long-term metabolic complications, including sarcopenia, it is recommended that individuals undergoing treatment with GLP-1 RAs receive adequate protein intake and appropriate micronutrient supplementation to preserve muscle mass and function, thereby maximizing the clinical benefits of therapy

[DOI] [PubMed] [Google Scholar] 496.Cheng X., Ji Z., Tsalkova T., Mei F

The Danish drugmaker found that liraglutide showed outstanding weight-reducing effects when used as a diabetes treatment (Victoza) and turned it into an obesity treatment